ABSTRACT Uroporphyrinogen I (URO) synthase [porpho-bilinogen ammonia-lyase (polymerizing), EC 4.3.1.8] activity increased when cultures of normal human bone marrow cells were incubated with erythropoietin. The increase of URO synthase activity was a linear function of erythropoietin concentration in the culture medium and was proportional to the extent of heme synthesis as determined by 5Fe incorporation into heme. The onset of the increase in URO synthase activity, which occurred on day 4 of incubation with erythropoietin, preceded by 3 days the appearance of hemoglobin in colonies derived from erythroid progenitor cells. These results indicate that induction of URO synthase in normal human bone marrow cells incubated with erythropoietin is an early event and that URO synthase activity is a useful quantitative index of erythroid differentiation.
The development of an in vitro culture technique for bone marrow cells, utilizing a semisolid medium, has provided a useful means for study of the proliferation and differentiation of cells that give rise to erythroid colonies (1, 2) . Early erythroid progenitor cells of human bone marrow are defined in this system as erythroid burst-forming units (BFU-E) which develop into hemoglobinized bursts after 14 days of incubation in the presence of erythropoietin (Ep) (3) . The late-stage erythroid progenitors are termed erythroid colony-forming cells (CFU-E) and are recognized as hemoglobinized colonies after 7 days of incubation with Ep (3) . A number of studies have been carried out to elucidate the process of erythroid differentiation morphologically by using this method (1-7), but few biochemical studies have been carried out to characterize enzymatic changes occurring during erythroid differentiation.
An increase in heme synthesis is an essential change that takes place during erythroid differentiation (8) . We therefore assessed the activity of the heme biosynthetic pathway during erythroid differentiation of normal human bone marrow cells in culture by measuring the rate of incorporation of radioactive precursors into heme and the activity of uroporphyrinogen I (URO) synthase [porphobilinogen ammonia-lyase (polymerizing), EC 4.3.1.81 as determined by a sensitive fluorometric assay (9) . We report that URO synthase is a sensitive and quantitative index of erythroid differentiation in normal human bone marrow cells and that it increases at an early stage in this process. (3, 6) .
MATERIALS
Mononuclear cells isolated from normal peripheral blood were also cultured as described above. Nucleated cells (3 X 105) were seeded in 1 ml of the methylcellulose-containing medium per plate. Hemoglobinized BFU-E were enumerated on day 14 as described above for the bone marrow cells.
URO Synthase Assay. Cells were collected from each dish by using a rubber policeman, transferred to a test tube by using a pasteur pipette, washed three times in 5 ml of modified F-12 medium (11) , and centrifuged at 600 X g for 5 min. URO synthase was measured by using the cell pellet derived from a 35-mm petri dish culture (equivalent to 2 X 105 cells). URO synthase catalyzes the condensation of four molecules of porphobilinogen to form the symmetrical cyclic tetrapyrrole uroporphyrinogen I. As described (9), the substrate, porphobilinogen, was at 100 ,M in the assay medium with 0.1 M phosphate buffer (pH 7.4); the product, uroporphyrinogen, was oxidized to uroporphyrin by exposure to room light for 30 min and then quantitated fluorometrically with a Hitachi PerkinElmer MPF4 fluorescence spectrophotometer equipped with an R-928 photomultiplier. The fluorescence spectrophotometer was calibrated daily with 0.1 ,uM coproporphyrin III in 0.14 M HCl as a standard.
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Abbreviations: BFU-E, erythroid burst-forming units (early erythroid progenitor cells); CFU-E, erythroid colony-forming cells (late erythroid progenitor cells); Ep, erythropoietin; URO, uroporphyrinogen I. with the modified F-12 medium (11) . After the addition of 1 ml of carrier hemoglobin solution containing 0.4 mg of hemoglobin, the heme was extracted into cyclohexanone as described (12 (2) and confirmed subsequently by others (4, 6) .
Incubation of cell lysates with porphobilinogen resulted in the generation of a fluorescence emission spectrum characteristic of uroporphyrin (13) . URO synthase activity was significantly greater in Ep-treated cultures than in untreated cultures (Fig. 1) .
URO synthase activity in cultures treated with Ep increased as a function of length of culture period (Fig. 2) . There was no significant difference in URO synthase activity in cultures with and without Ep at day 2 in culture. After day 4 in culture, however, URO synthase activity in the Ep-treated cultures had increased significantly compared with the untreated cultures. This increase was reproducible and preceded the appearance of visibly hemoglobinized erythroid colonies; these did not appear until after 7 days of incubation. By day 14 of incubation, URO synthase activity was approximately 15-fold greater in Ep-treated cultures than in cultures not incubated with Ep.
URO synthase activity showed a dose-dependent increase as a function of Ep concentrations in the culture (Fig. 3) . A linear increase in enzyme activity was observed for Ep concentrations up to 1.0 international unit/ml. Enzyme activity was also found to increase in a fashion related to the number of BFU (Fig. 4) .
The increase of URO synthase activity was proportional to the increase of 55Fe incorporation into heme in these cells (Fig.  5) , and the latter was also linearly related to the increase in the number of BFU-E. In contrast to these linear relationships between URO Although URO synthase activity increased linearly with Ep concentrations, the general rate of increase of URO synthase activity was greater than the increase in the number of BFU-E (Fig. 4) . These results suggest either that more erythroid cells are present per BFU-E or that URO synthase activity increases in each individual cell as more bursts are formed.
After 4 days of incubation, URO synthase activity was significantly greater in the Ep-treated cultures than in cultures not treated with Ep. Since morphologically recognizable erythroid colonies-i.e., well-hemoglobinized clusters of erythroblasts-were not observed on day 4 but appeared only after 7 days of incubation, the significant difference in the increased URO synthase activity observed on day 4 of incubation indicates that the increase in URO synthase activity occurs well before the appearance of hemoglobin formation. Sequential increases in early heme pathway enzymes including URO synthase have been found to occur during erythroid differentiation in the spleen of mice in response to Ep (15) and during the development of fetal mouse liver preceding the increase in hemoglobin (16) . That a similar sequential induction of heme pathway enzymes occurs during erythroid differentiation of mouse Friend virus erythroleukemia cells has been demonstrated (8) (19) .
Our findings also suggest that the induction of the fina zyme of the heme biosynthetic pathway may be an impo step in heme formation in erythroid cells. In this regard, important to note that the addition of hemin to culturi mouse Friend cells (12, (19) (20) (21) and mouse bone marrow (22) causes an increase in hemoglobin formation. In the pra study with normal human bone marrow cells, we also der strated that the extent of 55Fe incorporation into heme, w reflects ferrochelatase activity, was strongly correlated with the number of BFU-E. In agreement with this finding, protoporphyrin was detectable between days 10 and 14 only in Eptreated cultures (--1 pmol/106 cells), suggesting a relative block of ferrochelatase activity during erythroid differentiation. Therefore, the results of this study and similar findings in other erythroid systems strongly suggest that ferrochelatase is a rate-limiting enzymatic step for heme formation in developing erythroid cells (8, 15, 17, 19, 22, 23) .
It is noteworthy that these findings are in contrast to those observed with the liver. In the liver, regulation of heme biosynthesis appe.,rs to be primarily at the level of aminolevulinic acid synthase, the first enzyme of the heme biosynthetic pathway (24) . The basal level of hepatic aminolevulinic acid synthase activity is relatively low compared with that of other enzymes in the heme pathway, and synthesis of aminolevulinic acid synthase only increases in experimental situations when the need for heme synthesis is increased, whereas activities of other enzymes remain non-rate-limiting. Hemin is also known to suppress activity or synthesis of aminolevulinic acid synthase in the liver (24) . Therefore, the fact that URO synthase activity increases in normal human bone marrow cells in response to Ep indicates that, in erythroid cells, aminolevulinic acid synthase may not be the rate-limiting enzyme for heme formation. Induction of heme pathway enzymes including aminolevulinic acid synthase by hemin in mouse Friend erythroleukemia cells (12) and increases of erythroid colonies by hemin in normal mouse bone marrow cultures (22) also indicate that hemin does not exert a feedback control in the erythroid cells. Thus, it appears that the regulation of heme biosynthesis in the erythroid cells may be under a different system of control than that in liver cells.
The results of this study, using human bone marrow preparations, demonstrate that URO synthase activity is induced in response to Ep treatment in normal bone marrow cells. It is also clear from this study than an increase in URO synthase activity is an early process and a sensitive marker for erythroid differ55Fe entiation in human bone marrow cells. This study as 
